Pharma Firms Debate Novel Biotech Deals: How Much Competition Is Healthy?
Executive Summary
R&D productivity is best encouraged through "benchmarking" among a firm's own drug development centers rather than external competition with licensing partners, Merck Exec VP-Worldwide Basic Research Anthony Ford-Hutchinson, PhD, said